210 related articles for article (PubMed ID: 38678022)
21. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
[TBL] [Abstract][Full Text] [Related]
22. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
23. Are proton pump inhibitors really so dangerous?
Savarino V; Dulbecco P; Savarino E
Dig Liver Dis; 2016 Aug; 48(8):851-9. PubMed ID: 27321544
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
[TBL] [Abstract][Full Text] [Related]
25. The relationship between proton pump inhibitors and renal disease.
Morschel CF; Mafra D; Eduardo JCC
J Bras Nefrol; 2018; 40(3):301-306. PubMed ID: 30010692
[TBL] [Abstract][Full Text] [Related]
26. [Proton pump inhibitors and kidney].
Desbuissons G; Deray G; Mercadal L
Nephrol Ther; 2018 Apr; 14 Suppl 1():S115-S124. PubMed ID: 29274872
[TBL] [Abstract][Full Text] [Related]
27. Proton-pump Inhibitor Use and Myocardial Infarction: A Nested Case-Control Study in the UK Clinical Practice Research Datalink.
Qian Y; Jick S
Epidemiology; 2020 May; 31(3):423-431. PubMed ID: 31809341
[TBL] [Abstract][Full Text] [Related]
28. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
[TBL] [Abstract][Full Text] [Related]
29. Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank.
Pisanu C; Welander NZ; Rukh G; Schiöth HB; Mwinyi J
Biomed Pharmacother; 2021 Nov; 143():112234. PubMed ID: 34649359
[TBL] [Abstract][Full Text] [Related]
30. Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?
Ghosh G; Schnoll-Sussman F; Mathews S; Katz PO
Aliment Pharmacol Ther; 2020 Jan; 51(1):121-128. PubMed ID: 31664732
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
[TBL] [Abstract][Full Text] [Related]
33. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
Kamal F; Khan MA; Molnar MZ; Howden CW
J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
[TBL] [Abstract][Full Text] [Related]
34. The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study.
Douwes RM; Gomes-Neto AW; Eisenga MF; Van Loon E; Schutten JC; Gans ROB; Naesens M; van den Berg E; Sprangers B; Berger SP; Navis G; Blokzijl H; Meijers B; Bakker SJL; Kuypers D
PLoS Med; 2020 Jun; 17(6):e1003140. PubMed ID: 32542023
[TBL] [Abstract][Full Text] [Related]
35. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
36. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.
Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT
Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313
[TBL] [Abstract][Full Text] [Related]
37. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
38. Proton Pump Inhibitors, Associated Complications, and Alternative Therapies: A Shifting Risk Benefit Ratio.
Friedman AJ; Elseth AJ; Brockmeyer JR
Am Surg; 2022 Jan; 88(1):20-27. PubMed ID: 33560890
[TBL] [Abstract][Full Text] [Related]
39. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.
Rodríguez-Poncelas A; Barceló MA; Saez M; Coll-de-Tuero G
PLoS One; 2018; 13(10):e0204231. PubMed ID: 30332411
[TBL] [Abstract][Full Text] [Related]
40. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
